Elevated CaMKK2 activity is found within prostate20, hepatic21, and breast22 cancers, while loss of CaMKK2 has been shown to polarize TAMs to an anti-tumor phenotype in murine breast cancer and lymphoma models22,23. The gene discussed is CAMKK2; the disease is neoplasm.